Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study confirms an association between TNF-α antagonist exposure and alopecia, indicating a class effect among the medications examined.

This document provides a legal disclaimer and offers no research findings.

This study found that among anti-TNF-α agents, certolizumab is the least likely to cause paradoxical reactions such as psoriatic alopecia and appears to be an effective and safe option for managing psoriasis and PsA while minimizing these risks.

This abstract describes a program with various presentations and events focused on Canadian excellence in rheumatology but reports no new research findings.